Hypoglycemia in Diabetes Mellitus.
1Barbara Freeland, DNP, RN, ACNS-BC, CDE, is a Clinical Assistant Professor, School of Nursing, University of Michigan, Ann Arbor, Michigan.
Home Healthcare Now
|September 1, 2017
Summary
Hypoglycemia, a serious diabetes complication, requires recognizing risk factors and prevention strategies. Home care clinicians must assess patient understanding of low blood glucose and its treatment.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Hypoglycemia is a critical acute complication associated with diabetes treatment.
- Effective self-management education is crucial for individuals using glucose-lowering medications.
- Understanding and preventing low blood glucose levels are essential for patient safety.
Purpose of the Study:
- To emphasize the importance of recognizing hypoglycemia risk factors.
- To highlight the necessity of integrating hypoglycemia prevention into diabetes self-management education.
- To underscore the role of home care clinicians in assessing patient knowledge.
Main Methods:
- This study is a review of current literature and clinical guidelines on hypoglycemia management in diabetes.
- Analysis of risk factors, preventative measures, and educational strategies was performed.
- Evaluation of the role of healthcare providers in patient education was considered.
Main Results:
- Key risk factors for hypoglycemia were identified.
- Effective prevention strategies were outlined.
- The critical need for comprehensive patient education was confirmed.
Conclusions:
- Recognizing and mitigating hypoglycemia risk factors is paramount in diabetes care.
- Diabetes self-management education must include thorough instruction on hypoglycemia prevention and treatment.
- Home care clinicians play a vital role in ensuring patients understand and can manage hypoglycemia effectively.
Related Concept Videos
01:15Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:06Oral Hypoglycemic Agents: Glinides
747
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
747